comparemela.com

Latest Breaking News On - Shih shin ru - Page 1 : comparemela.com

Taiwan s science academy fined for biosafety lapses after lab worker contracts COVID-19 | Science

Taiwan s science academy fined for biosafety lapses after lab worker contracts COVID-19 | Science
science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.

CECC publishes regulations for use of Merck s COVID-19 pill

Taipei, Jan. 12 (CNA) The Central Epidemic Command Center (CECC) on Wednesday publicized regulations on the use of the oral antiviral pill molnupiravir, made by drugmaker Merck, which has been granted emergency use authorization (EUA) in Taiwan.

Molnupiravir plan unchanged despite new data, CECC says

The Central Epidemic Command Center’s (CECC) plan to procure the oral antiviral drug molnupiravir remains unchanged, even though a final analysis of clinical tests showed that the drug was less effective against COVID-19 than hoped for, Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the CECC, said on Saturday. Molnupiravir reduced the risk of hospitalization and death among high-risk cases by 30 percent, Chen said, citing drugmaker Merck’s final analysis of data from 1,433 trial participants. Initial data released last month showed an efficacy of about 50 percent. The CECC has a ordered the drug from the US company and does

Virologist calls for more vaccination as new COVID-19 variant emerges

Taipei, Nov. 27 (CNA) Virologist Ho Mei-shang (何美鄉) has called for vaccinations to be increased in Taiwan in light of a new COVID-19 variant that the World Health Organization (WHO) has described as "concerning."

Plan to buy COVID-19 pills unchanged despite lower efficacy: CECC

Taipei, Nov. 27 (CNA) Taiwan's plan to procure the oral antiviral drug, molnupiravir, remains unchanged, Health and Welfare Minister Chen Shih-chung (陳時中) said Saturday, although the drug has been shown to be less effective in reducing COVID-19 hospitalizations and deaths in its final analysis.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.